Selurampanel
From Infogalactic: the planetary knowledge core
File:Selurampanel.svg | |
Systematic (IUPAC) name | |
---|---|
N-[7-Isopropyl-6-(2-methylpyrazol-3-yl)-2,4-dioxo-1H-quinazolin-3-yl]methanesulfonamide
|
|
Identifiers | |
CAS Number | 912574-69-7 |
ATC code | None |
PubChem | CID: 45381907 |
ChemSpider | 32698379 |
Chemical data | |
Formula | C16H19N5O4S |
Molecular mass | 377.418 g/mol |
|
|
|
Selurampanel (INN, code name BGG492) is a drug closely related to the quinoxalinedione series which acts as a competitive antagonist of the AMPA and kainate receptors and, as of 2015, is being investigated in clinical trials by Novartis for the treatment of epilepsy.[1][2][3] It has also been studied in the acute treatment of migraine, and was found to produce some pain relief, but with a relatively high rate of side effects.[4]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- AMPA receptor antagonists
- Anticonvulsants
- Antimigraine drugs
- Kainate receptor antagonists
- Pyrazoles
- Quinazolines
- Sulfonamides
- Nervous system drug stubs